FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to the use of 2-hydroxy-3-methoxybenzaldehyde isonicotinoyl hydrazone as a compound showing antiasthmatic, anti-inflammatory and anti-allergic activities. EFFECT: decreased toxicity of the compound proposed. 5 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIALLERGIC AND ANTI-IFLAMMATORY AGENT | 1999 |
|
RU2170091C2 |
ANTIALLERGENIC AND ANTIINFLAMMATORY AGENT | 1999 |
|
RU2160097C1 |
MAGNESIUM 5-HYDROXYNICOTINATE SHOWING COMPLEX ANTIDIABETIC EFFECT | 1998 |
|
RU2136663C1 |
PREPARATION FOR TUBERCULOSIS TREATMENT | 1994 |
|
RU2080114C1 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIINFLAMMATORY, BRONCHOLYTIC, ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2448961C1 |
MONO- OR DICARBOXYLIC ACID ZINC SALTS SHOWING GASTROPROTECING ACTIVITY | 1995 |
|
RU2116292C1 |
5-ETHYL-2-AMINO-1,3,4-THIADIAZOLE DERIVATIVES WITH ANESTHETIC, ANTI-INFLAMMATORY, ANTI-ALLERGIC AND ANALGETIC ACTIVITY | 2016 |
|
RU2651572C2 |
GAMMA-HYDROXYPROPYLAMMONIUM-5-HYDROXYNICOTINATE ELICITING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND HYPOLIPIDEMIC ACTIVITY | 2003 |
|
RU2245329C1 |
INHALATION COMPOSITION FOR BRONCHIAL ASTHMA TREATMENT | 1992 |
|
RU2054932C1 |
2-AMINO-1,3,4-THIADIZOLE DERIVATIVES SHOWING ANTIMETASTATIC ACTIVITY | 1995 |
|
RU2114109C1 |
Authors
Dates
1999-10-20—Published
1997-06-11—Filed